Avricore Health Inc.AVCR.V
Health Care · Health Care Equipment & Services · TSX-V · Canada · avricore.com
Avricore Health Inc. is a pharmacy service innovator based in Vancouver, Canada, focused on acquiring and developing early-stage technologies to advance pharmacy services. The company provides HealthTab, a turnkey point-of-care testing platform that enables pharmacies to test up to 27 biomarkers on-site for screening and managing chronic conditions such as diabetes. Listed on TSXV as AVCR and OTCQB as AVCRF.
Key ratios
FCF / Sales
-12.3%TTM
2024
17.2%2023
-10.4%2022
-92.2%
Net margin
-84.7%TTM
2024
-14.0%2023
-20.1%2022
-46.3%
ROA
-23.1%TTM
2024
4.6%2023
-14.3%2022
-16.8%
ROE
-86.1%TTM
2024
-33.6%2023
-35.3%2022
-39.3%
Recent news
HealthTab™ and HeartEye Open New Referral Pathway into Community Pharmacy
Avricore Grants Options
HealthTab Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK
Avricore Health Closes $1.254 Million Financing
Avricore Health Announces $1.25 Million Financing
Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform
Track AVCR.V in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer